Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $7.2700 (-2.15%) ($7.2700 - $7.2700) on Fri. Apr. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.54% (three month average) | RSI | 22 | Latest Price | $7.2700(-2.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.9% a day on average for past five trading days. | Weekly Trend | ATRA declines -10.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(47%) IBB(45%) ARKK(44%) ARKG(43%) XAR(41%) | Factors Impacting ATRA price | ATRA will decline at least -2.27% in a week (0% probabilities). VIXM(-39%) VXX(-26%) UNG(-18%) USO(-11%) TLT(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.27% (StdDev 4.54%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.7(-219.67%) | Resistance Level | $8.64 | 5 Day Moving Average | $7.6(-4.34%) | 10 Day Moving Average | $7.95(-8.55%) | 20 Day Moving Average | $8.64(-15.86%) | To recent high | -53.6% | To recent low | 0% | Market Cap | $540m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |